graphpad prims 5.01 Search Results


90
GraphPad Software Inc prime 5.01
Prime 5.01, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prime 5.01/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
prime 5.01 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc graphpad prim 5.01
Graphpad Prim 5.01, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/graphpad prim 5.01/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
graphpad prim 5.01 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc graph pad prims v 5.01
Graph Pad Prims V 5.01, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/graph pad prims v 5.01/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
graph pad prims v 5.01 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc prim 5.01 software
Prim 5.01 Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prim 5.01 software/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
prim 5.01 software - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc prime 5 windows version 5.01
Prime 5 Windows Version 5.01, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prime 5 windows version 5.01/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
prime 5 windows version 5.01 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc prime 5 for windows
Prime 5 For Windows, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prime 5 for windows/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
prime 5 for windows - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc graphpad prim 8
Analysis of 131 I-ANA biodistribution in vivo and <t>inhibition</t> of tumor growth ( a ) Biodistribution of 131 I-ANAs in tissue of mice with PC3 xenografts (n = 5). The results are presented as the mean ± SD (error bars). ( b ) Blood clearance and tumor concentration of 131 I-ANAs with time. ( c ) Tumor growth in nude mice bearing PC3 tumor xenografts; mean ± SD, n = 10 in the 0.9% NaCl and ANA groups, n = 30 in the 131 I-ANA group (****P < 0.0001, 131 I-ANAs vs. 0.9% NaCl; ***P < 0.001, 131 I-ANAs vs. ANA, two-way ANOVA with Tukey's multiple comparisons test. The tumor growth inhibition rates were expressed as the mean and SE (13.21 ± 6.79%, 131 I-ANAs vs. ANA; 28.33 ± 5.01%, 131 I-ANAs vs. 0,9% NaCl and 17.41 ± 5.18%, ANAs vs. 0,9% NaCl) ( d ) Kaplan‒Meier survival curve showing the effects of 131 I-ANAs on the median survival of PC3 tumor-bearing mice (***P = 0.0006; GraphPad Prim 8; log-rank (Mantel‒Cox) test; chi-square 14.89, df = 2). Compared with 0.9% NaCl (control), treatment with 131 I-ANAs or ANAs resulted in a 1.83- (64 vs. 35 days) or 1.43-fold (50 vs. 35 days) increase in median survival, respectively (GraphPad 8, survival). ( e ), ( f ) Light micrograph of HE staining (200 ×) in liver, which showed hemorrhagic zones and mild degeneration (arrow white) at 72 and 168 h after injection. ( g ), ( h ) Light micrograph of HE staining (200 ×) of kidney, which showed replicated endothelial cells of the artery (gray white) at 72 and 168 h after injection. ( i ), ( j ) Light micrograph of HE staining (400 ×) of the tumor, which showed large nucleoli, bizarre nucleoli, and abnormal mitotic nuclei (black arrow) at 72 and 168 h after injection. Notes: White arrow: hemorrhagic zones; Gray arrow: reactive inflammation; Black arrow: large nucleoli, bizarre nuclei, abnormal mitotic nuclei.
Graphpad Prim 8, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/graphpad prim 8/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
graphpad prim 8 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Merck KGaA amicon ultra-0.5 centrifugal filter unit (30kda and 10 kda mwco)
Analysis of 131 I-ANA biodistribution in vivo and <t>inhibition</t> of tumor growth ( a ) Biodistribution of 131 I-ANAs in tissue of mice with PC3 xenografts (n = 5). The results are presented as the mean ± SD (error bars). ( b ) Blood clearance and tumor concentration of 131 I-ANAs with time. ( c ) Tumor growth in nude mice bearing PC3 tumor xenografts; mean ± SD, n = 10 in the 0.9% NaCl and ANA groups, n = 30 in the 131 I-ANA group (****P < 0.0001, 131 I-ANAs vs. 0.9% NaCl; ***P < 0.001, 131 I-ANAs vs. ANA, two-way ANOVA with Tukey's multiple comparisons test. The tumor growth inhibition rates were expressed as the mean and SE (13.21 ± 6.79%, 131 I-ANAs vs. ANA; 28.33 ± 5.01%, 131 I-ANAs vs. 0,9% NaCl and 17.41 ± 5.18%, ANAs vs. 0,9% NaCl) ( d ) Kaplan‒Meier survival curve showing the effects of 131 I-ANAs on the median survival of PC3 tumor-bearing mice (***P = 0.0006; GraphPad Prim 8; log-rank (Mantel‒Cox) test; chi-square 14.89, df = 2). Compared with 0.9% NaCl (control), treatment with 131 I-ANAs or ANAs resulted in a 1.83- (64 vs. 35 days) or 1.43-fold (50 vs. 35 days) increase in median survival, respectively (GraphPad 8, survival). ( e ), ( f ) Light micrograph of HE staining (200 ×) in liver, which showed hemorrhagic zones and mild degeneration (arrow white) at 72 and 168 h after injection. ( g ), ( h ) Light micrograph of HE staining (200 ×) of kidney, which showed replicated endothelial cells of the artery (gray white) at 72 and 168 h after injection. ( i ), ( j ) Light micrograph of HE staining (400 ×) of the tumor, which showed large nucleoli, bizarre nucleoli, and abnormal mitotic nuclei (black arrow) at 72 and 168 h after injection. Notes: White arrow: hemorrhagic zones; Gray arrow: reactive inflammation; Black arrow: large nucleoli, bizarre nuclei, abnormal mitotic nuclei.
Amicon Ultra 0.5 Centrifugal Filter Unit (30kda And 10 Kda Mwco), supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/amicon ultra-0.5 centrifugal filter unit (30kda and 10 kda mwco)/product/Merck KGaA
Average 90 stars, based on 1 article reviews
amicon ultra-0.5 centrifugal filter unit (30kda and 10 kda mwco) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Millipore genelute plasmid miniprep kit
Analysis of 131 I-ANA biodistribution in vivo and <t>inhibition</t> of tumor growth ( a ) Biodistribution of 131 I-ANAs in tissue of mice with PC3 xenografts (n = 5). The results are presented as the mean ± SD (error bars). ( b ) Blood clearance and tumor concentration of 131 I-ANAs with time. ( c ) Tumor growth in nude mice bearing PC3 tumor xenografts; mean ± SD, n = 10 in the 0.9% NaCl and ANA groups, n = 30 in the 131 I-ANA group (****P < 0.0001, 131 I-ANAs vs. 0.9% NaCl; ***P < 0.001, 131 I-ANAs vs. ANA, two-way ANOVA with Tukey's multiple comparisons test. The tumor growth inhibition rates were expressed as the mean and SE (13.21 ± 6.79%, 131 I-ANAs vs. ANA; 28.33 ± 5.01%, 131 I-ANAs vs. 0,9% NaCl and 17.41 ± 5.18%, ANAs vs. 0,9% NaCl) ( d ) Kaplan‒Meier survival curve showing the effects of 131 I-ANAs on the median survival of PC3 tumor-bearing mice (***P = 0.0006; GraphPad Prim 8; log-rank (Mantel‒Cox) test; chi-square 14.89, df = 2). Compared with 0.9% NaCl (control), treatment with 131 I-ANAs or ANAs resulted in a 1.83- (64 vs. 35 days) or 1.43-fold (50 vs. 35 days) increase in median survival, respectively (GraphPad 8, survival). ( e ), ( f ) Light micrograph of HE staining (200 ×) in liver, which showed hemorrhagic zones and mild degeneration (arrow white) at 72 and 168 h after injection. ( g ), ( h ) Light micrograph of HE staining (200 ×) of kidney, which showed replicated endothelial cells of the artery (gray white) at 72 and 168 h after injection. ( i ), ( j ) Light micrograph of HE staining (400 ×) of the tumor, which showed large nucleoli, bizarre nucleoli, and abnormal mitotic nuclei (black arrow) at 72 and 168 h after injection. Notes: White arrow: hemorrhagic zones; Gray arrow: reactive inflammation; Black arrow: large nucleoli, bizarre nuclei, abnormal mitotic nuclei.
Genelute Plasmid Miniprep Kit, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/genelute plasmid miniprep kit/product/Millipore
Average 90 stars, based on 1 article reviews
genelute plasmid miniprep kit - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Millipore nitrocellulose membrane
Analysis of 131 I-ANA biodistribution in vivo and <t>inhibition</t> of tumor growth ( a ) Biodistribution of 131 I-ANAs in tissue of mice with PC3 xenografts (n = 5). The results are presented as the mean ± SD (error bars). ( b ) Blood clearance and tumor concentration of 131 I-ANAs with time. ( c ) Tumor growth in nude mice bearing PC3 tumor xenografts; mean ± SD, n = 10 in the 0.9% NaCl and ANA groups, n = 30 in the 131 I-ANA group (****P < 0.0001, 131 I-ANAs vs. 0.9% NaCl; ***P < 0.001, 131 I-ANAs vs. ANA, two-way ANOVA with Tukey's multiple comparisons test. The tumor growth inhibition rates were expressed as the mean and SE (13.21 ± 6.79%, 131 I-ANAs vs. ANA; 28.33 ± 5.01%, 131 I-ANAs vs. 0,9% NaCl and 17.41 ± 5.18%, ANAs vs. 0,9% NaCl) ( d ) Kaplan‒Meier survival curve showing the effects of 131 I-ANAs on the median survival of PC3 tumor-bearing mice (***P = 0.0006; GraphPad Prim 8; log-rank (Mantel‒Cox) test; chi-square 14.89, df = 2). Compared with 0.9% NaCl (control), treatment with 131 I-ANAs or ANAs resulted in a 1.83- (64 vs. 35 days) or 1.43-fold (50 vs. 35 days) increase in median survival, respectively (GraphPad 8, survival). ( e ), ( f ) Light micrograph of HE staining (200 ×) in liver, which showed hemorrhagic zones and mild degeneration (arrow white) at 72 and 168 h after injection. ( g ), ( h ) Light micrograph of HE staining (200 ×) of kidney, which showed replicated endothelial cells of the artery (gray white) at 72 and 168 h after injection. ( i ), ( j ) Light micrograph of HE staining (400 ×) of the tumor, which showed large nucleoli, bizarre nucleoli, and abnormal mitotic nuclei (black arrow) at 72 and 168 h after injection. Notes: White arrow: hemorrhagic zones; Gray arrow: reactive inflammation; Black arrow: large nucleoli, bizarre nuclei, abnormal mitotic nuclei.
Nitrocellulose Membrane, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nitrocellulose membrane/product/Millipore
Average 90 stars, based on 1 article reviews
nitrocellulose membrane - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Millipore b-casein
Analysis of 131 I-ANA biodistribution in vivo and <t>inhibition</t> of tumor growth ( a ) Biodistribution of 131 I-ANAs in tissue of mice with PC3 xenografts (n = 5). The results are presented as the mean ± SD (error bars). ( b ) Blood clearance and tumor concentration of 131 I-ANAs with time. ( c ) Tumor growth in nude mice bearing PC3 tumor xenografts; mean ± SD, n = 10 in the 0.9% NaCl and ANA groups, n = 30 in the 131 I-ANA group (****P < 0.0001, 131 I-ANAs vs. 0.9% NaCl; ***P < 0.001, 131 I-ANAs vs. ANA, two-way ANOVA with Tukey's multiple comparisons test. The tumor growth inhibition rates were expressed as the mean and SE (13.21 ± 6.79%, 131 I-ANAs vs. ANA; 28.33 ± 5.01%, 131 I-ANAs vs. 0,9% NaCl and 17.41 ± 5.18%, ANAs vs. 0,9% NaCl) ( d ) Kaplan‒Meier survival curve showing the effects of 131 I-ANAs on the median survival of PC3 tumor-bearing mice (***P = 0.0006; GraphPad Prim 8; log-rank (Mantel‒Cox) test; chi-square 14.89, df = 2). Compared with 0.9% NaCl (control), treatment with 131 I-ANAs or ANAs resulted in a 1.83- (64 vs. 35 days) or 1.43-fold (50 vs. 35 days) increase in median survival, respectively (GraphPad 8, survival). ( e ), ( f ) Light micrograph of HE staining (200 ×) in liver, which showed hemorrhagic zones and mild degeneration (arrow white) at 72 and 168 h after injection. ( g ), ( h ) Light micrograph of HE staining (200 ×) of kidney, which showed replicated endothelial cells of the artery (gray white) at 72 and 168 h after injection. ( i ), ( j ) Light micrograph of HE staining (400 ×) of the tumor, which showed large nucleoli, bizarre nucleoli, and abnormal mitotic nuclei (black arrow) at 72 and 168 h after injection. Notes: White arrow: hemorrhagic zones; Gray arrow: reactive inflammation; Black arrow: large nucleoli, bizarre nuclei, abnormal mitotic nuclei.
B Casein, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/b-casein/product/Millipore
Average 90 stars, based on 1 article reviews
b-casein - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc prim software version 5.01
Analysis of 131 I-ANA biodistribution in vivo and <t>inhibition</t> of tumor growth ( a ) Biodistribution of 131 I-ANAs in tissue of mice with PC3 xenografts (n = 5). The results are presented as the mean ± SD (error bars). ( b ) Blood clearance and tumor concentration of 131 I-ANAs with time. ( c ) Tumor growth in nude mice bearing PC3 tumor xenografts; mean ± SD, n = 10 in the 0.9% NaCl and ANA groups, n = 30 in the 131 I-ANA group (****P < 0.0001, 131 I-ANAs vs. 0.9% NaCl; ***P < 0.001, 131 I-ANAs vs. ANA, two-way ANOVA with Tukey's multiple comparisons test. The tumor growth inhibition rates were expressed as the mean and SE (13.21 ± 6.79%, 131 I-ANAs vs. ANA; 28.33 ± 5.01%, 131 I-ANAs vs. 0,9% NaCl and 17.41 ± 5.18%, ANAs vs. 0,9% NaCl) ( d ) Kaplan‒Meier survival curve showing the effects of 131 I-ANAs on the median survival of PC3 tumor-bearing mice (***P = 0.0006; GraphPad Prim 8; log-rank (Mantel‒Cox) test; chi-square 14.89, df = 2). Compared with 0.9% NaCl (control), treatment with 131 I-ANAs or ANAs resulted in a 1.83- (64 vs. 35 days) or 1.43-fold (50 vs. 35 days) increase in median survival, respectively (GraphPad 8, survival). ( e ), ( f ) Light micrograph of HE staining (200 ×) in liver, which showed hemorrhagic zones and mild degeneration (arrow white) at 72 and 168 h after injection. ( g ), ( h ) Light micrograph of HE staining (200 ×) of kidney, which showed replicated endothelial cells of the artery (gray white) at 72 and 168 h after injection. ( i ), ( j ) Light micrograph of HE staining (400 ×) of the tumor, which showed large nucleoli, bizarre nucleoli, and abnormal mitotic nuclei (black arrow) at 72 and 168 h after injection. Notes: White arrow: hemorrhagic zones; Gray arrow: reactive inflammation; Black arrow: large nucleoli, bizarre nuclei, abnormal mitotic nuclei.
Prim Software Version 5.01, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prim software version 5.01/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
prim software version 5.01 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Analysis of 131 I-ANA biodistribution in vivo and inhibition of tumor growth ( a ) Biodistribution of 131 I-ANAs in tissue of mice with PC3 xenografts (n = 5). The results are presented as the mean ± SD (error bars). ( b ) Blood clearance and tumor concentration of 131 I-ANAs with time. ( c ) Tumor growth in nude mice bearing PC3 tumor xenografts; mean ± SD, n = 10 in the 0.9% NaCl and ANA groups, n = 30 in the 131 I-ANA group (****P < 0.0001, 131 I-ANAs vs. 0.9% NaCl; ***P < 0.001, 131 I-ANAs vs. ANA, two-way ANOVA with Tukey's multiple comparisons test. The tumor growth inhibition rates were expressed as the mean and SE (13.21 ± 6.79%, 131 I-ANAs vs. ANA; 28.33 ± 5.01%, 131 I-ANAs vs. 0,9% NaCl and 17.41 ± 5.18%, ANAs vs. 0,9% NaCl) ( d ) Kaplan‒Meier survival curve showing the effects of 131 I-ANAs on the median survival of PC3 tumor-bearing mice (***P = 0.0006; GraphPad Prim 8; log-rank (Mantel‒Cox) test; chi-square 14.89, df = 2). Compared with 0.9% NaCl (control), treatment with 131 I-ANAs or ANAs resulted in a 1.83- (64 vs. 35 days) or 1.43-fold (50 vs. 35 days) increase in median survival, respectively (GraphPad 8, survival). ( e ), ( f ) Light micrograph of HE staining (200 ×) in liver, which showed hemorrhagic zones and mild degeneration (arrow white) at 72 and 168 h after injection. ( g ), ( h ) Light micrograph of HE staining (200 ×) of kidney, which showed replicated endothelial cells of the artery (gray white) at 72 and 168 h after injection. ( i ), ( j ) Light micrograph of HE staining (400 ×) of the tumor, which showed large nucleoli, bizarre nucleoli, and abnormal mitotic nuclei (black arrow) at 72 and 168 h after injection. Notes: White arrow: hemorrhagic zones; Gray arrow: reactive inflammation; Black arrow: large nucleoli, bizarre nuclei, abnormal mitotic nuclei.

Journal: Scientific Reports

Article Title: Safety assessment, radioiodination and preclinical evaluation of antinuclear antibody as novel medication for prostate cancer in mouse xenograft model

doi: 10.1038/s41598-023-45984-6

Figure Lengend Snippet: Analysis of 131 I-ANA biodistribution in vivo and inhibition of tumor growth ( a ) Biodistribution of 131 I-ANAs in tissue of mice with PC3 xenografts (n = 5). The results are presented as the mean ± SD (error bars). ( b ) Blood clearance and tumor concentration of 131 I-ANAs with time. ( c ) Tumor growth in nude mice bearing PC3 tumor xenografts; mean ± SD, n = 10 in the 0.9% NaCl and ANA groups, n = 30 in the 131 I-ANA group (****P < 0.0001, 131 I-ANAs vs. 0.9% NaCl; ***P < 0.001, 131 I-ANAs vs. ANA, two-way ANOVA with Tukey's multiple comparisons test. The tumor growth inhibition rates were expressed as the mean and SE (13.21 ± 6.79%, 131 I-ANAs vs. ANA; 28.33 ± 5.01%, 131 I-ANAs vs. 0,9% NaCl and 17.41 ± 5.18%, ANAs vs. 0,9% NaCl) ( d ) Kaplan‒Meier survival curve showing the effects of 131 I-ANAs on the median survival of PC3 tumor-bearing mice (***P = 0.0006; GraphPad Prim 8; log-rank (Mantel‒Cox) test; chi-square 14.89, df = 2). Compared with 0.9% NaCl (control), treatment with 131 I-ANAs or ANAs resulted in a 1.83- (64 vs. 35 days) or 1.43-fold (50 vs. 35 days) increase in median survival, respectively (GraphPad 8, survival). ( e ), ( f ) Light micrograph of HE staining (200 ×) in liver, which showed hemorrhagic zones and mild degeneration (arrow white) at 72 and 168 h after injection. ( g ), ( h ) Light micrograph of HE staining (200 ×) of kidney, which showed replicated endothelial cells of the artery (gray white) at 72 and 168 h after injection. ( i ), ( j ) Light micrograph of HE staining (400 ×) of the tumor, which showed large nucleoli, bizarre nucleoli, and abnormal mitotic nuclei (black arrow) at 72 and 168 h after injection. Notes: White arrow: hemorrhagic zones; Gray arrow: reactive inflammation; Black arrow: large nucleoli, bizarre nuclei, abnormal mitotic nuclei.

Article Snippet: The tumor growth inhibition rates were expressed as the mean and SE (13.21 ± 6.79%, 131 I-ANAs vs. ANA; 28.33 ± 5.01%, 131 I-ANAs vs. 0,9% NaCl and 17.41 ± 5.18%, ANAs vs. 0,9% NaCl) ( d ) Kaplan‒Meier survival curve showing the effects of 131 I-ANAs on the median survival of PC3 tumor-bearing mice (***P = 0.0006; GraphPad Prim 8; log-rank (Mantel‒Cox) test; chi-square 14.89, df = 2).

Techniques: In Vivo, Inhibition, Concentration Assay, Control, Staining, Injection